Amit Tirosh

専門分野: Endocrinologist
36年の経験
話します:
English, Hebrew
勤務先: イスラエル, ラマト・ガン, シェバ医療センター
Heads a NET service; international VHL expert panelist and contributor to clinical guidelines.
Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Amit Tirosh医師とのパッケージ取引を探る

手術を選択

PNET (Pancreatic neuroendocrine tumor) Advanced Diagnostics Program at Sheba Medical Center (Top 10 Worldwide)

$5,000

パッケージあたり

パッケージにはクリニックが提供する標準的な医療サービスと宿泊、送迎などの追加特典が含まれます。

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Department:

The Endocrinology and Diabetes Research Center

The Endocrine Institute & Endocrine Oncology Bioinformatics Lab

Specialties:

Neuroendocrine Tumors

Professional Profile

Prof. Amit Tirosh is a senior endocrinologist with extensive expertise in the management of neuroendocrine tumors (NETs). He serves as the Head of the Neuroendocrine Tumors Service at the Institute of Endocrinology, Sheba Medical Center.

His clinical and academic focus includes hereditary syndromes associated with neuroendocrine tumor development. Prof. Tirosh is affiliated with the National Institutes of Health (NIH) in the field of MEN1 syndrome. He is also part of an international expert panel on von Hippel–Lindau (VHL) disease and has contributed to clinical guidelines for the management of VHL patients. At Sheba Medical Center, he acts as the primary contact physician within the multidisciplinary VHL clinic.

Research and Academic Activity

Prof. Tirosh leads an active research program focused on bioinformatics in endocrine oncology, with particular emphasis on neuroendocrine tumors. As Head of the Endocrine Oncology Bioinformatics Laboratory, he collaborates with leading research institutions in the United States, Italy, and Germany, as well as with scientists from the Weizmann Institute of Science.

In his role at the Endocrinology and Diabetes Research Center, he provides patients with advanced, state-of-the-art treatment options for NETs. He is also actively involved in teaching and regularly lectures medical students at Tel Aviv University’s Faculty of Medicine.

Clinical Expertise

Endocrinology

Neuroendocrine tumors (NETs)

Peptide Receptor Radionuclide Therapy (PRRT)

Current Position

Head of Neuroendocrine Tumors Service,

The Endocrine Institute & Endocrine Oncology Bioinformatics Lab,

The Endocrinology and Diabetes Research Center

Education and Training

MD, Hadassah Medical School, Hebrew University of Jerusalem

Residency in Internal Medicine, Assaf HaRofeh Medical Center

Fellowship in Endocrinology, Rabin Medical Center

Advanced training in Neuroendocrine Tumors and Endocrine Tumor Genetics, National Institutes of Health (Maryland, USA)

Board Certification

Endocrinology

Professional Memberships

Israeli Society of Endocrinology

American Endocrine Society

European Neuroendocrine Tumors Society

Scientific Publications

Prof. Tirosh is the author of more than 40 peer-reviewed publications in leading medical journals, including JAMA, Oncology, Gastroenterology, Cancer, Journal of Clinical Endocrinology & Metabolism, and Radiology.

Selected articles include:

Postoperative hyperglycemia following insulinoma resection: incidence and management

Nockel P, Tirosh A, et al.

Radiation exposure from CT surveillance in patients with VHL-associated pancreatic tumors

Tirosh A, Journy N, et al.

Radioguided surgery using Gallium-68 DOTATATE in neuroendocrine tumors

El Lakis M, Tirosh A, et al.